CD8A and neoplasm: In comparison, PD1 levels on the CD8+ T cell subtypes were increased on the circulating cells (Fig. 8d) and PD-L1 levels were increased on the treatment-resistant CD8+ TCM-like cells in the tumor and PBMC relative to the healthy donor controls (Fig. 8e).